Preparing your space
Preparing your space
Conditions & Recovery · ScienceDaily Nutrition · September 26, 2026

Tirzepatide, sold as Mounjaro and Zepbound, activated calorie-burning brown fat in obese mice, revealing a potential metabolic effect beyond appetite suppression. If confirmed in humans, the finding could help explain the drug’s powerful benefits and inspire more comprehensive treatments for obesity and diabetes.
Originally published by ScienceDaily Nutrition. We curate and add context; they did the reporting.
Read the full story at ScienceDaily Nutrition ↗